Boston Trust Walden Corp increased its position in The Clorox Company (NYSE:CLX – Free Report) by 4.0% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 284,821 shares of the company’s stock after purchasing an additional 10,913 shares during the quarter. Boston Trust Walden Corp’s holdings in Clorox were worth $46,258,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Brooklyn Investment Group grew its stake in Clorox by 163.8% in the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after acquiring an additional 95 shares during the period. Prospera Private Wealth LLC acquired a new position in shares of Clorox during the third quarter worth approximately $27,000. Continuum Advisory LLC lifted its holdings in shares of Clorox by 300.0% in the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after purchasing an additional 138 shares in the last quarter. Quarry LP grew its position in Clorox by 99.1% in the 2nd quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after purchasing an additional 114 shares during the period. Finally, Carolina Wealth Advisors LLC bought a new stake in Clorox during the 3rd quarter valued at $48,000. 78.53% of the stock is owned by institutional investors.
Clorox Trading Up 0.7 %
NYSE CLX opened at $159.80 on Tuesday. The business’s fifty day moving average is $162.76 and its 200-day moving average is $158.50. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62. The stock has a market capitalization of $19.78 billion, a price-to-earnings ratio of 55.68, a PEG ratio of 2.92 and a beta of 0.42. The Clorox Company has a one year low of $127.60 and a one year high of $171.37.
Clorox Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be issued a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a yield of 3.05%. The ex-dividend date is Wednesday, January 29th. Clorox’s dividend payout ratio (DPR) is 170.04%.
Wall Street Analyst Weigh In
A number of research analysts have weighed in on CLX shares. TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and raised their price objective for the company from $155.00 to $170.00 in a research note on Wednesday, November 6th. StockNews.com cut shares of Clorox from a “buy” rating to a “hold” rating in a research report on Sunday, January 5th. Barclays decreased their price objective on Clorox from $139.00 to $130.00 and set an “underweight” rating for the company in a report on Friday, January 17th. Evercore ISI dropped their target price on Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a report on Monday, October 14th. Finally, JPMorgan Chase & Co. upped their price target on Clorox from $167.00 to $171.00 and gave the stock a “neutral” rating in a report on Thursday, January 16th. Four equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has given a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $156.07.
View Our Latest Stock Analysis on CLX
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Articles
- Five stocks we like better than Clorox
- What Do S&P 500 Stocks Tell Investors About the Market?
- How to Invest in Small Cap Stocks
- What Does Downgrade Mean in Investing?
- These Are the Dividend Stocks Insiders Bought in January
- What is the Nasdaq? Complete Overview with History
- How the ‘No Buy’ Trend of 2025 Is Boosting These 3 Stocks
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.